AU Patent

AU2021253592A1 — Cyclobenzaprine treatment for sexual dysfunction

Assigned to Tonix Pharmaceuticals Holding Corp · Expires 2022-11-10 · 4y expired

What this patent protects

The present disclosure provides a pharmaceutical composition comprising therapeutically effective amounts of cyclobenzaprine and one or more agents, and methods of treating and/or preventing sexual dysfunction.

USPTO Abstract

The present disclosure provides a pharmaceutical composition comprising therapeutically effective amounts of cyclobenzaprine and one or more agents, and methods of treating and/or preventing sexual dysfunction.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021253592A1
Jurisdiction
AU
Classification
—
Expires
2022-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Tonix Pharmaceuticals Holding Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.